Epidemiologie, Familiarität und Genetik der Zwangsstörung
Themenschwerpunkt
Abstract
Zusammenfassung: Zahlreiche epidemiologische Studien der letzten Jahre haben weltweit eine Lebenszeitprävalenz der Zwangsstörung von 1-3 % ermittelt. Es findet sich in der Allgemeinbevölkerung eine leicht erhöhte Erkrankungsrate bei Frauen. Aktuelle kontrollierte Familienstudien zeigen eindeutig eine familiäre Transmission der Zwangsstörung auf. Diese Befunde deuten, zusammen mit einigen allerdings methodisch schwächeren Zwillingsstudien, auf eine genetische Erkrankungsdisposition hin. Zahlreiche genetische Assoziationsstudien sind bislang bei der Zwangsstörung mit zumeist inkonsistenten Befunden durchgeführt worden. Gerade Kandidatengene des serotonergen und dopaminergen Systems zeigten keine konsistenten Assoziationen. In methodisch optimierten aktuellen Studien zeigten sich viel versprechende Assoziationen zu Polymorphismen des Glutamat-Transportergens (SLC1A1) und des OLIG2-Gens (Oligodendrocyte lineage transcription factor 2). Methodische Implikationen für zukünftige genetische Untersuchungen bei der als ätiopathogenetisch heterogen imponierenden Zwangsstörung werden diskutiert.
Abstract: During the last years, epidemiological studies have confirmed a worldwide lifetime-prevalence rate of obsessive-compulsive disorder (OCD) of 1-3 %. In general population samples a female preponderance is found in most of the studies. Recent controlled family studies have clearly demonstrated a familial transmission of OCD. Acknowledging findings from twin studies, these data support a genetic contribution to the predisposition for OCD. Numerous genetic association studies have been conducted so far. However, especially candidate genes of the serotonergic and dopaminergic system have failed to archive robust replications in OCD. In some recent studies applying optimized methodological strategies, associations between interesting polymorphisms of the glutamat-transporter gene (SLC1A1) and the OLIG2-gene (Oligodendrocyte lineage transcription factor 2) and OCD have been found. Methodological implications for future directions of genetic investigations in OCD will be discussed addressing also the heterogeneity of OCD.
References
2004). Association of a glutamate (NMDA) subunit receptor gene (GRIN2B) with obsessive-compulsive disorder: A preliminary study. Psychopharmacology (Berl) , 174 , 530– 538
(2006). Glutamate transporter gene SLC1A1 associated with obsessive-compulsive disorder. Archives of General Psychiatry , 63 , 769– 776
(1998). Epidemiology of obsessive-compulsive disorder. British Journal of Psychiatry , 35(Suppl.) , 2– 6
(1999). Association of the serotonin transporter promoter regulatory region polymorphism and obsessive-compulsive disorder. Molecular Psychiatry , 4 , 463– 466
(1998). Investigation of dopamine system genes in obsessive-compulsive disorder. Psychiatric Genetics , 8 , 163– 169
(1992). A family study of obsessive-compulsive disorder. Archives of General Psychiatry , 49 , 362– 8
(1981). Twin and family studies of anxiety, phobic, and obsessive disorders. In D.F. Klein & J. G. Rabkin (Eds.), Anxiety: New research and changing concepts (pp. 117-136). New York: Raven
(2000). An association study between 5-HTTLPR polymorphism, COMT polymorphism, and Tourette's syndrome. Psychiatry Research , 97 , 93– 100
(2004). Lack of evidence for association between serotonin transporter gene (5-HTTLPR) and obsessive-compulsive disorder by case control and family association study in humans. Neuroscience Letters , 363 , 154– 156
(2004). Twelve-month prevalence of obsessive-compulsive disorder in Konya, Turkey. Comprehensive Psychiatry , 45 , 367– 374
(2002). No association between obsessive-compulsive disorder and the 5-HT1Dβ rezeptor gene. American Journal of Psychiatry , 159 , 1783– 1785
(2006). Association testing of the positional and functional candidate gene SLC1A1/EAAC1 in early-onset obsessive-compulsive disorder. Archives of General Psychiatry , 6 , 778– 785
(2001). Sexually dimorphic relationship of a 5-HT2A promoter polymorphism with obsessive-compulsive disorder. Biological Psychiatry , 49 , 385– 388
(2003). Lack of association of catechol-O-methyltransferase gene polymorphism in obsessive-compulsive disorder. Depression and Anxiety , 18 , 41– 45
(2007). Impulsiveness in obsessive compulsive disorder - results from a family study. Acta Psychiatrica Scandinavica , 115 , 41– 47
(2000). Association between obsessive-compulsive disorder and polymorphisms of genes encoding components of the serotonergic and dopaminergic pathways. European Neuropsychopharmacology , 10 , 205– 209
(2003). Connections among symptoms of obsessive-compulsive disorder and posttraumatic stress disorder: A case series. Behaviour Research and Therapy , 41 , 1029– 1041
(1990). Beyond the serotonin hypothesis: A role for dopamine in some forms of obsessive compulsive disorder?. Journal of Clinical Psychiatry , 51(Suppl.) , 36– 43; discussion 55-58
(2000). Prevalence, quality of life and psychosocial function in obsessive- compulsive disorder and subclinical obsessive-compulsive disorder in northern Germany. European Archives of Psychiatry and Clinical Neuroscience , 250 , 262– 268
(2001). Comorbidity of obsessive-compulsive disorder and subclinical obsessive-compulsive disorder in northern Germany. European Archives of Psychiatry and Clinical Neuroscience , 251 , 130– 136
(2006). Familiality of obsessive-compulsive disorder in non-clinical and clinical subjects. American Journal of Psychiatry , 163 , 1986– 1992
(2006). Alexithymia in obsessive compulsive disorder - results from a family study. Psychotherapy and Psychosomatics , 75 , 312– 318
(2006). 5HT2c receptor activation induces grooming behaviour in rats: Possible correlations with obsessive- compulsive disorder. Neuropsychopharmacology in Hungary , 8 , 23– 28
(1998). Delayed obsessive-compulsive disorder symptom exacerbation after a single dose of a serotonin antagonist in fluoxetin-treated but not untreated patients. Psychopharmacology (Berl) , 140 , 434– 444
(2004). Serotonergic dissection of obsessive compulsive symptoms: A challenge study with m-chlorophenylpiperazine and sumatriptan. Neuropsychobiology , 50 , 200– 205
(2003). Sequence variants of the brain-derived neurotrophic factor (BDNF) gene are strongly associated with obsessive-compulsive disorder. American Journal of Human Genetics , 73 , 370– 376
(2003). Investigating the role of dopaminergic and serotonergic candidate genes in obsessive-compulsive disorder. European Neuropsychopharmacology , 13 , 93– 98
(1965). Similar and dissimilar manifestations of obsessive-compulsive neurosis in monozygotic twins. American Journal of Psychiatry , 121 , 1171– 1175
(2000). Obsessive and compulsive symptoms in a general population sample of female twins. American Journal of Medical Genetics , 96 , 791– 796
(2001). Phenomenology of obsessive-compulsive disorder in Taiwan. Psychiatry and Clinical Neurosciences , 55 , 623– 627
(1999). Family-based association studies support a sexually dimorphic effect of COMT and MAO-A on genetic susceptibility to obsessive-compulsive disorder. Biological Psychiatry , 45 , 1178– 1189
(1988). The epidemiology of obsessive-compulsive disorder in five US communities. Archives of General Psychiatry , 45 , 1094– 1099
(1980). Life events and onset of obsessive compulsive disorder. International Journal of Social Psychiatry , 113 , 823– 832
(2006). The genetic studies of obsessive-compulsive disorder and its future directions. Yonsei Medical Journal , 47 , 443– 454
(2000). Obsessive-compulsive disorder and the promoterregion polymorphism (5-HTTLPR) in the serotonin transporter gene (SLC6A4): A negative association study in the Afrikaner population. International Journal of Neuropsychopharmacology , 3 , 327– 331
(1994). Epidemiology of psychiatric disorders in Edmonton. Obsessive-compulsive disorder. Acta Psychiatrica Scandinavica , Suppl. 376 , 24– 35
(1996). Obsessive compulsive disorder: Familial development history, symptomatology, comorbidity and course with special reference to gender related differences. British Journal of Psychiatry , 169 , 101– 107
(1996). Association of anxiety-related traits with a polymorphisms in the serotonin transporter gene regulatory region. Science , 274 , 1527– 1531
(2004). Distinct neural correlates of washing, checking, and hoarding symptom dimensions in obsessive-compulsive disorder. Archives of General Psychiatry , 61 , 564– 576
(1998). Evidence for linkage disequilibrium between serotonin transporter protein gene (SLC6A4) and obsessive-compulsive disorder. Molecular Psychiatry , 3 , 270– 273
(1984). Life events and personality traits in obsessive compulsive neurosis. British Journal of Psychiatry , 144 , 185– 189
(1987). Familial aspects of obsessive-compulsive neurosis. British Journal of Psychiatry , 151 , 528– 34
(2004). Association analysis of the catechol-o-methyltransferase (COMT), serotonin transporter (5-HTT) and serotonin 2A receptor (5HT2A) gene polymorphisms with obsessive-compulsive disorder. Genes, Brain and Behavior , 3 , 75– 79
(2005). Obsessive-compulsive disorder phenotypes: Implications for genetic studies. Molecular Psychiatry , 10 , 258– 275
(2003). Association between the dopamine receptor D4(DRD4) gene and obsessive-compulsive disorder. American Journal of Medical Genetics B: Neuropsychiatric Genetics , 116 , 55– 59
(2004). Prevalence of obsessive-compulsive disorder in Iran. BMC Psychiatry , 4 , 2–
(2007). Transmission disequilibrium analysis of the functional 5-HT3A receptor variant C178T in early-onset obsessive-compulsive disorder. Journal of Psychopharmacology , Jan. 26 [Epub ahead of print] , –
(2006). Transmission disequilibrium of polymorphic variants in the tryptophan hydroxylase-2 gene in children and adolescents with obsessive-compulsive disorder. International Journal of Neuropsychopharmacology , 9 , 437– 442
(2000). A family study of obsessive-compulsive disorder. Archives of General Psychiatry , 57 , 358– 363
(2002). Recent findings in the genetics of OCD. Journal of Clinical Psychiatry , 63(Suppl. 6) , 30– 33
(1995). A family study of obsessive compulsive disorder. American Journal of Psychiatry , 152 , 76– 84
(1986). Clinical characteristics and family history in DSM-III obsessive compulsive disorder. American Journal of Psychiatry , 143 , 317– 322
(1994). The epidemiology and differential diagnosis of obsessive compulsive disorder. Journal of Clinical Psychiatry , 55(Suppl. 10) , 5– 10
(1992). The epidemiology and clinical features of obsessive compulsive disorder. Psychiatric Clinics of North America , 15 , 743– 758
(2000). Association between homozygosity at the COMT gene locus and obsessive compulsive disorder. American Journal of Medical Genetics B: Neuropsychiatric Genetics , 96 , 721– 727
(1999). A 40-years follow-up of patients with obsessive compulsive disorder. Archives of General Psychiatry , 56 , 121– 127
(1996). The neurobiology of obsessive-compulsive disorder. Neuroscientist , 2 , 300– 305
(2007). A genetic family-based association study of OLIG2 in obsessive-compulsive disorder. Archives of General Psychiatry , 64 , 209– 214
(1992). Obsessive compulsive disorder in childhood and adolescence: A clinical study. Journal of Child Psychology and Psychiatry , 33 , 1025– 1037
(1992). Human dopamine transporter gene (DAT1) maps to chromosome 5p15. and displays a VNTR. Genomics , 14 , 1104– 1106
(2004). Transmission disequilibrium studies in children and adolescents with obsessive-compulsive disorders pertaining to polymorphisms of genes of the serotonergic pathway. Journal of Neural Transmission , 111 , 817– 825
(2002). 5-HT2A promoter polymorphism -1438G/A in children and adolescents with obsessive-compulsive disorders. Molecular Psychiatry , 7 , 1054– 1057
(1994). The cross national epidemiology of obsessive compulsive disorder. The Cross National Collaborative Group. Journal of Clinical Psychiatry , 55(Suppl.) , 5– 10
(2007). A large case-control study of common functional SLC6A4 and BDNF variants in obsessive-compulsive disorder. Neuropsychopharmacology , Mar 21 (Epub ahead of print) , –
(2000). Genetic aspects of obsessive-compulsive disorder. Obsessive-Compulsive Spectrum Disorders , 23 , 535– 544
(2005). Evidence for the gamma-amino-butyric acid type B receptor 1 (GABBR1) gene as a susceptibility factor in obsessive-compulsive disorder. American Journal of Medical Genetics B: Neuropsychiatric Genetics , 134 , 25– 29
(